Pegylated Interferon Lambda Effective in Preventing Severe C

For a predominantly vaccinated adult population with COVID-19, the incidence of hospitalization or emergency department visit is significantly lower for those receiving a single dose of pegylated interferon lambda versus placebo.

Related Keywords

Canada , Stanford , California , United States , Brazil , Gilmar Reis , , Healthday News , New England Journal , Stanford Biosecurity , Pandemic Preparedness , Eiger Biopharmaceuticals ,